World's Best Scientists 2026 revealed!
Pierre M. Laduron

Pierre M. Laduron

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
13296
World Ranking
14889
National Ranking
262

Overview

Pierre M. Laduron is affiliated with Janssen in Belgium. Their professional work is primarily connected to this institution, indicating involvement in the pharmaceutical or biomedical research sector.

Though specific details regarding recent publications or research articles are not available, Pierre M. Laduron's profile reflects engagement in scientific research at Janssen. Without recent papers or detailed topics provided, a precise characterization of their research focus cannot be established from the current data.

There are no listed frequent co-authors associated with Pierre M. Laduron, which may suggest independent research activity or collaboration patterns that are not extensively documented in the given source.

No information is available on the scientist's frequent venues for publication, which typically provide insight into disciplinary focus or preferred journals and conferences.

The data does not include information about books published by Pierre M. Laduron, therefore no commentary on contributions to academic book literature can be made.

Fields of study and subfields related to their research have not been specified. Similarly, there are no main topics of work outlined, which limits the ability to identify specialized areas of expertise or thematic concentrations in research activities.

No awards or recognitions have been recorded for Pierre M. Laduron in the data provided, leaving this aspect of the professional profile unaddressed.

As no indication of being deceased is noted, the information reflects an active or at least currently living researcher. The profile remains factual and neutral, reflecting the available data without supplementary interpretation.

Best Publications

  • [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

    J E Leysen;C J Niemegeers;J M Van Nueten;P M Laduron

  • Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

    J.E. Leysen;F. Awouters;L. Kennis;P.M. Laduron

  • Serotonergic component of neuroleptic receptors

    Josée E. Leysen;Carlos J. E. Niemegeers;Jan P. Tollenaere;Pierre M. Laduron

  • Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.

    Josée E. Leysen;W. Gommeren;Pierre M. Laduron

  • Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

    J. E. Leysen;W. Gommeren;P. Van Gompel;J. Wynants

  • Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

    Claude Garret;Anne Carruette;Veronique Fardin;Saliha Moussaoui

  • Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

    Pierre M. Laduron;Josée E. Leysen

  • Spiperone: A ligand of choice for neuroleptic receptors: 2. Regional distribution and in vivo displacement of neuroleptic drugs

    Pierre M. Laduron;P.F.M. Janssen;Josée E. Leysen

  • Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain.

    A. Schotte;J. E. Leysen;P. M. Laduron

  • Axonal transport of opiate receptors in capsaicin-sensitive neurones

    Pierre M. Laduron

  • Characterization and regional distribution of serotonin S2-receptors in human brain.

    A. Schotte;A. Schotte;J.M. Maloteaux;J.M. Maloteaux;P.M. Laduron;P.M. Laduron

  • Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution.

    Patrick Kitabgi;William Rostène;Monique Dussaillant;Alain Schotte

  • Criteria for receptor sites in binding studies.

    Pierre M. Laduron

  • Specific in vivo binding of neuroleptic drugs in rat brain

    P. Laduron;J. Leysen

  • Axoplasmic transport of muscarinic receptors.

    Pierre Laduron

  • In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole

    P M Laduron;P F Janssen;W Gommeren;J E Leysen

  • In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain

    Pierre M. Laduron;Paul F.M. Janssen;Josee E. Leysen

  • Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.

    Jean-Pierre Galizzi;Michel Fosset;Georges Romey;Pierre Laduron

  • Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain.

    J. Leysen;P. Laduron

  • A serotonergic component of neuroleptic receptors.

    Leysen Je;Laduron Pm

Frequent Co-Authors

Josée E. Leysen
Josée E. Leysen VU University Medical Center
Michel Lazdunski
Michel Lazdunski Centre national de la recherche scientifique, CNRS
Paul M. Vanhoutte
Paul M. Vanhoutte University of Hong Kong
André Trouet
André Trouet Université Catholique de Louvain
Serge Mignani
Serge Mignani Universidade da Madeira
A. Donny Strosberg
A. Donny Strosberg Université Paris Cité
Florian Lesage
Florian Lesage Centre national de la recherche scientifique, CNRS
Georges Romey
Georges Romey Centre national de la recherche scientifique, CNRS
Yves-Jacques Schneider
Yves-Jacques Schneider Université Catholique de Louvain
William Rostène
William Rostène Institut de la Vision

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Pierre M. Laduron

Recently Published Articles